Public Market

Secondary Issues

Tatva Chintan Pharma raises Rs.200-Cr via QIP

Press Release  

Tatva Chintan Pharm Chem Limited has raised INR 200 crore via a Qualified Institutional Placement (QIP). ICICI Securities was the Sole Lead Manager. Prominent investors in the QIP included Nippon MF, ICICI Prudential MF, Goldman Sachs, Morgan Stanley, among others Tatva Chintan is a specialty chemical manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents, phase transfer catalysts, electrolyte salts for super capacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals and bromine flame retardants.